AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2019
May 14, 2019
30786_dirs_2019-05-13_1810fc9c-664f-4f87-bb12-110fd69be9c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-05-13
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-13 | Bio-Rad B Common Stock | M | 37000 | $75.38 | Acquired | 298642 | Direct |
| 2019-05-13 | Bio-Rad B Common Stock | F | 22833 | $296.28 | Disposed | 275809 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-13 | Non-Qualified Stock Option (right to buy) | $75.38 | M | 37000 | Disposed | 2019-06-10 | Bio-Rad B Common Stock (37000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 412562 | Direct |
| Bio-Rad B Common Stock | 12771 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these shares.
F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3: The option vested in five equal annual installments beginning on June 10, 2010.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13